Clinical trial
Extent and Durability of Immune Response Following Seasonal Influenza Vaccination in Healthy Volunteers
NCT03163342 is registered in ClinicalTrials.gov with Altimmune, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Extent and Durability of Immune Response Following Seasonal Influenza Vaccination in Healthy Volunteers
- Lead sponsor
- Altimmune, Inc.
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- May 8, 2017
- Completion date
- June 15, 2018
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
influenza